Decoding PharmEasy’s latest down round logic

The proposed rights issue, at a 90% valuation cut, makes one thing clear: it’s the investors who are calling the shots here.

7 July, 20234 min
0
Decoding PharmEasy’s latest down round logic

You may also like

Business
Story image

The weight-loss wave that’s changing India—one sector at a time

Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.

Internet
Story image

Fintech Hala’s new millions

One of the largest-ever funding rounds among the Middle East startups, Carrefour’s latest exits and other updates from the week.

Health
Story image

How Kerala brought its infant mortality rate to a historic low

Decades of investment in health and social infrastructure went into getting the southern state’s infant mortality rate down to 5 deaths per 1,000 live births—far lower than the national average of 25.